Who is Metro International Biotech LLC?

Metro International Biotech LLC was founded in 2017. The Company's line of business includes providing commercial physical and biological research and development.

What is Metro international biotech mib-626?

Metro International Biotech has assembled a team of industry-leading scientists to drive its lead compound, MIB-626, through clinical development and fuel the Company’s robust R&D engine, building a library of next-generation analogs with tissue-selective NAD+ increasing properties. To enable longer, healthier lives.

Should you buy biotech stocks?

Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how their treatments fare in Food & Drug Administration clinical trials and real-world applications. Picking the right biotech stocks means the difference between treading water and impressive outperformance.